Compile Data Set for Download or QSAR
Report error Found 82 Enz. Inhib. hit(s) with all data for entry = 7666
TargetNeurogenic locus notch homolog protein 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209891(US9273014, 20)
Affinity DataIC50: 1.40nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209895(US9273014, 24)
Affinity DataIC50: 1.40nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209891(US9273014, 20)
Affinity DataIC50: 1.60nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209896(US9273014, 25)
Affinity DataIC50: 1.70nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209874(US9273014, 3)
Affinity DataIC50: 1.80nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209874(US9273014, 3)
Affinity DataIC50: 1.90nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209895(US9273014, 24)
Affinity DataIC50: 2.10nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209876(US9273014, 5)
Affinity DataIC50: 2.30nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209888(US9273014, 17)
Affinity DataIC50: 2.40nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209881(US9273014, 10)
Affinity DataIC50: 2.5nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209898(US9273014, 27)
Affinity DataIC50: 2.70nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209902(US9273014, 31)
Affinity DataIC50: 2.80nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209898(US9273014, 27)
Affinity DataIC50: 2.80nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209896(US9273014, 25)
Affinity DataIC50: 2.90nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209907(US9273014, 36)
Affinity DataIC50: 3nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209883(US9273014, 12)
Affinity DataIC50: 3nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209880(US9273014, 9 | US9273014, 11)
Affinity DataIC50: 3nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209893(US9273014, 22)
Affinity DataIC50: 3.10nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209883(US9273014, 12)
Affinity DataIC50: 3.20nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209892(US9273014, 21)
Affinity DataIC50: 3.30nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209897(US9273014, 26)
Affinity DataIC50: 3.40nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209884(US9273014, 13)
Affinity DataIC50: 3.40nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209880(US9273014, 9 | US9273014, 11)
Affinity DataIC50: 3.70nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209897(US9273014, 26)
Affinity DataIC50: 3.70nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209887(US9273014, 16)
Affinity DataIC50: 3.70nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209900(US9273014, 29)
Affinity DataIC50: 3.90nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209876(US9273014, 5)
Affinity DataIC50: 4nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209890(US9273014, 19)
Affinity DataIC50: 4nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209901(US9273014, 30 | US9273014, 35)
Affinity DataIC50: 4.20nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209901(US9273014, 30 | US9273014, 35)
Affinity DataIC50: 4.30nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209904(US9273014, 33)
Affinity DataIC50: 4.30nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209871(US9273014, 2)
Affinity DataIC50: 4.30nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209886(US9273014, 15)
Affinity DataIC50: 4.40nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209878(US9273014, 7)
Affinity DataIC50: 4.40nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209878(US9273014, 7)
Affinity DataIC50: 4.40nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209886(US9273014, 15)
Affinity DataIC50: 4.40nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209877(US9273014, 6)
Affinity DataIC50: 4.5nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209889(US9273014, 18)
Affinity DataIC50: 4.60nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209902(US9273014, 31)
Affinity DataIC50: 4.60nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209894(US9273014, 23)
Affinity DataIC50: 4.70nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209890(US9273014, 19)
Affinity DataIC50: 4.80nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209901(US9273014, 30 | US9273014, 35)
Affinity DataIC50: 4.80nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209905(US9273014, 34)
Affinity DataIC50: 4.80nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209899(US9273014, 28)
Affinity DataIC50: 4.80nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209871(US9273014, 2)
Affinity DataIC50: 4.90nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209884(US9273014, 13)
Affinity DataIC50: 4.90nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

LigandPNGBDBM209911(US9273014, Comparative Compound 47 | US9427442, Co...)
Affinity DataIC50: 5.10nMAssay Description:The Notch-CBF1 (C-promoter binding factor I) cell based transactivation assay is based on the ability of the released Notch intracellular domain frag...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209881(US9273014, 10)
Affinity DataIC50: 5.40nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209888(US9273014, 17)
Affinity DataIC50: 5.70nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

TargetNeurogenic locus notch homolog protein 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM209900(US9273014, 29)
Affinity DataIC50: 5.70nMAssay Description:The pharmacological properties of the compounds of this invention may be confirmed by a number of biological assays.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2017
Entry Details
US Patent

Displayed 1 to 50 (of 82 total ) | Next | Last >>
Jump to: